deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT02885012

Crossover Study From Macitentan or Bosentan Over to Ambrisentan (Letairis)

A Safety and Clinical Efficacy Study Measuring Echocardiographic Composite Comparing Ambrisentan (Letairis®) After a Switch From Bosentan (Tracleer®) or Macintentan (Opsumit®) in Treatment of Pulmonary Arterial Hypertension (PAH)

Sponsor: Medical University of South Carolina

Conditions Pulmonary Arterial Hypertension
Interventions Ambrisentan
Updated 9 times since 2017 Last updated: Apr 5, 2019 Started: Jun 30, 2016 Primary completion: Jul 7, 2017 Completion: Jul 7, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study ending due to lack of enrollment.

Other terminated trials from Medical University of South Carolina

See all terminations from Medical University of South Carolina

Other Pulmonary Arterial Hypertension trials with similar outcome

Browse all Pulmonary Arterial Hypertension trials

Listed as NCT02885012, this PHASE4 trial focuses on Pulmonary Arterial Hypertension and remains terminated or withdrawn. Sponsored by Medical University of South Carolina, it has been updated 9 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotRecruiting~May 2019 – ~Jan 2021 · 20 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE4

▶ Show 4 earlier versions

  1. May 2019 — Jan 2021 [monthly]

    Terminated PHASE4

    Status: Recruiting → Terminated

  2. Jun 2018 — May 2019 [monthly]

    Recruiting PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University of South Carolina
  • Ochsner Health System
Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations